| bibliographicCitation |
de Bruyn G, Wang J, Purvis A, Ruiz MS, Adhikarla H, Alvi S, Bonaparte MI, Brune D, Bueso A, Canter RM, Ceregido MA, Deshmukh S, Diemert D, Finn A, Forrat R, Fu B, Gallais J, Griffin P, Grillet M, Haney O, Henderson JA, Koutsoukos M, Launay O, Torres FM, Masotti R, Michael NL, Park J, Rivera-Medina DM, Romanyak N, Rook C, Schuerman L, Sher LD, Tavares-Da-Silva F, Whittington A, Chicz RM, Gurunathan S, Savarino S, Sridhar S, de Bruyn G, Wang J, Purvis A, Ruiz MS, Adhikarla H, Alvi S, Bonaparte MI, Brune D, Bueso A, Canter RM, Ceregido MA, Deshmukh S, Diemert D, Finn A, Forrat R, Fu B, Gallais J, Griffin P, Grillet M, Haney O, Henderson JA, Koutsoukos M, Launay O, Torres FM, Masotti R, Michael NL, Park J, Rivera-Medina DM, Romanyak N, Rook C, Schuerman L, Sher LD, Tavares-Da-Silva F, Whittington A, Chicz RM, Gurunathan S, Savarino S, Sridhar S, Mohammed A, Valérie B, Jennifer B, Ben-Ghezala I, Breuer T, Breymeier C, Conrad A, Holmqvist C, Costa-Araujo C, Coux F, Dellanno C, Dussol B, Essink B, Garrido J, Girodet P, Gonzalez C, Grosbois M, Hammond J, He C, Homlqvist C, Hudzina K, Hutchens M, Jackson Booth P, Joaquin A, Kandasamy R, Kasztejna J, Keefer M, Kimmel M, Kresge M, Laine F, Lefebvre M, Lopez D, Lourdes MP, Maakaroun-Vermesse Z, Malishchak C, Menard L, Mendoza S, Moore P, Mulamalla M, Mulholland P, Nicolas J, Ogbuagu O, Ortiz J, Perroud AP, Peyton G, Purvis Y, Raabe V, Rivas E, Rouphael N, Roy B, Sagot L, Sater N, Schwartz H, Severance R, Shi J, Sobieszczyk M, Stevens C, Thuy TP, Toma R, Tong T, Tourneux S, Treanor J, Turet N, Froget R, Walsh S, White J, del Campo Perez V, Perez Breva L, Rojo Conejo P, Ruiz Antoraz MB, Chin T, Fribbens C, Phillipson A, Kaminski R, Emmett S, Hebert C, Birch T, Roberson R, Zacher J, Gelu-Maury S, Loryne L, Davis Y. Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study. eClinicalMedicine. 2023 Aug;62():102109. doi: 10.1016/j.eclinm.2023.102109. |